Literature DB >> 7320471

The diagnosis and classification of gastritis and duodenitis.

W M Weinstein.   

Abstract

There are specific and nonspecific categories of gastritis and duodenitis. In each category, the mucosal pattern may be erosive or nonerosive. Specific refers to distinctive patterns of inflammation associated with defined clinical syndromes. These are rare in the stomach and include granulomatous disorders and hypertrophic gastropathies. In the duodenal bulb they include Crohn's disease and any other disorder that may affect the proximal small bowel. Endoscopy diagnoses nonspecific erosive disease of the stomach and duodenal bulb. Histology diagnoses nonspecific, nonerosive gastritis (NNG) and duodenitis (NND). The major interest in NNG and NND is in their potential as pathogenic risk factors for other disorders. Although NNG and NND may theoretically cause symptoms, provocative tests need to be devised to prove this. Confusion in the classifications of NNG and NND often arises because clinicians, radiologists, endoscopists, and pathologists use similar terms to mean different things.

Entities:  

Mesh:

Year:  1981        PMID: 7320471

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

Review 1.  Gastritis.

Authors:  R G Strickland
Journal:  Springer Semin Immunopathol       Date:  1990

2.  [Source of variation in the diagnosis of Helicobacter pylori-associated multifocal atrophic gastritis.]

Authors:  Luis Eduardo Bravo; Juan Carlos Bravo; José Luis Realpe; Guillermo Zarama; MarÍa Blanca Piazuelo; Pelayo Correa
Journal:  Colomb Med (Cali)       Date:  2008-01

Review 3.  Gastrointestinal intolerance and bleeding with non-narcotic analgesics.

Authors:  K J Ivey
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 4.  Nonulcer dyspepsia.

Authors:  W G Thompson
Journal:  Can Med Assoc J       Date:  1984-03-01       Impact factor: 8.262

5.  Nodular duodenitis. Pathologic and clinical characteristics in patients with end-stage renal disease.

Authors:  G R Zukerman; B A Mills; R E Koehler; A Siegel; H R Harter; K DeSchryver-Kecskemeti
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.